Histone Lysine-Specific Methyltransferases and Demethylases in Carcinogenesis: New Targets for Cancer Therapy and Prevention

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|13|5|558-579

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.5, 2013-06, pp. : 558-579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 898-913

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Drug Discovery Targeting Histone Methyltransferases: An Update

By  

Current Medicinal Chemistry, Vol. 22, Iss. 17, 2015-06 ,pp. : 2075-2086

Bentham Science Publishers

Access to resources Recommend Favorite

Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 22, Iss. 39, 2016-12 ,pp. : 5943-5947

Bentham Science Publishers

Access to resources Recommend Favorite

Lysine-specific demethylase 1 as a potential therapeutic target

By Stavropoulos Pete   Hoelz André  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 6, 2007-06 ,pp. : 809-820

Informa Healthcare

Access to resources Recommend Favorite

Protein Tyrosine Phosphatases, New Targets for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 6, Iss. 6, 2006-09 ,pp. : 519-532

Bentham Science Publishers

Access to resources Recommend Favorite